PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $26,682
Award facts
- Contract value 100% obligated
- $26,681.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 26, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,681.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price, non-set-aside contract is scheduled for completion by January 27, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement designated SPE2DX and running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen's parent company, Cencora, Inc., maintains a substantial IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, reflecting the company's established role as a critical pharmaceutical distributor for federal medical procurement. The company's contract portfolio with defense and veteran healthcare agencies demonstrates capability in delivering a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award was competitively procured without set-aside restrictions, consistent with AmerisourceBergen's demonstrated ability to compete on a full and open basis for federal medical supply requirements.
Quick answers
Who was awarded contract SPE2D826FA3YU?
SPE2D826FA3YU was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 26, 2026.
How much is contract SPE2D826FA3YU worth?
The government has obligated $26,682 on SPE2D826FA3YU.
Is contract SPE2D826FA3YU an order under another contract?
Yes. SPE2D826FA3YU is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3YU competed?
The extent of competition for SPE2D826FA3YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award